| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
10,743 |
9,629 |
$554K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
5,198 |
4,917 |
$375K |
| S9088 |
Services provided in an urgent care center (list in addition to code for service) |
19,293 |
17,260 |
$325K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
4,164 |
3,768 |
$294K |
| 87428 |
|
737 |
643 |
$34K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
273 |
255 |
$28K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
672 |
589 |
$23K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
380 |
376 |
$20K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
925 |
436 |
$12K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
577 |
535 |
$7K |
| 81002 |
|
1,549 |
1,398 |
$4K |
| 81025 |
|
211 |
199 |
$2K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
101 |
94 |
$1K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
173 |
128 |
$1K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
32 |
24 |
$861.01 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
81 |
49 |
$776.02 |
| 90715 |
|
27 |
24 |
$522.13 |
| 81003 |
|
146 |
134 |
$314.63 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
27 |
24 |
$298.02 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
306 |
257 |
$66.05 |
| J7611 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg |
207 |
130 |
$7.07 |